Good morning.
Tape's got one story: memory. The historic unwind in MU/SNDK/Kioxia leaves the group washed out, but Kioxia just printed from inside it — F2Q guide implying ~+30% ASP, SSD & Storage revenue +390% YoY, ¥800bn buyback. That's not a peak cycle; that's a pricing power tell. WCLD +54% off lows, +8% YTD — cloud bid intact.
AMZN anchors the tape: AWS grew 36.7%, FASTEST IN 18 QUARTERS, backlog +36% QoQ to $496bn, capex RAISED to ~$220bn mainly because memory costs more. The largest memory buyers on earth lift capex because of memory while saying they still can't satisfy 2027 demand. MSFT backs it up — 30m+ paid Copilot seats, ~10m net adds in one quarter, double the prior pace; Goldman added to Conviction Buy. PLTR's setup into the print is clean: record 1Q obligations imply ~$1,030mm of 2Q government revenue, +86% YoY.
Asia: CXMT plans a second Beijing fab with financing talks ongoing — that's a Chinese equipment buy, not a CXMT one. Japan's nuclear restart cycle keeps ripping; beABLE +42% since IPO.
Four themes. First: memory panic vs. reality — HBM crowd-out is structural, TrendForce sees only 24% supply bit growth in 2027; this unwind is positioning, not fundamentals. Second: CPO goes production — NVDA's SVP declared mass production, scale-up bandwidth runs 10x scale-out; LITE/COHR own the InP laser moat, HIMX is microLED optionality at a reasonable entry (down 18% QTD). Third: AI demand is now contractual — AMD's warrants with Meta/OpenAI, up to 6GW of Instinct deployment with vesting hurdles to $600, lock the pipeline. Fourth: power gates everything — xAI's 8GW of 2027 demand sits locked into OEM schedules, but supply-side underwrites only 3.5-5GW; SPCX lock-ups start Aug 6.
We'll hit up MU, AMZN, MSFT first, then get to optics — LITE, COHR, HIMX.
Mixed underneath: oncology volume accelerated, and the xT CDx approval de-risks the 2027 ASP step-up. Data licensing backlog grew with additional multiyear deals. But data gross margins DECLINED YoY, hereditary stayed weak, and MRD grew 38% QoQ with only 10% of reps actually selling it. They're waiting for Personalis ASPs before pushing. That's the tell — the whole strategy is waiting on this deal.
"The quarterly beat and guidance raise were relatively modest, and the Personalis acquisition appears likely to dilute profitability in the coming year."
That's Stifel's hangup. BTIG's buy thesis is longer-dated — the CDx approval, the guidance raise, MRD at 10% penetration. Same risk, different time horizons.
Bear: The beat was modest, data gross margins are heading the wrong way, and Personalis dilutes profitability for at least the next year. Trading below the deal termination threshold puts the entire strategic narrative at risk. Hold until the landmines clear.
Verdict: Market priced a 22% comms push-out like a write-off. Stock dropped 21.88% to ~$258 last week. PT cuts were equally brutal — KeyBanc $500→$371, Truist $550→$428 — but both kept their ratings, and the new targets imply 44-66% upside from here. That divergence is the signal.
Q2 itself was solid: adjusted EPS $2.22 in line, revenue $4.375B (+23% YoY), beat. Full-year guide went UP to $9.30 on the Superior Group acquisition, even as core guidance came down. Backlog hit a record $21.4B (+30% YoY).
MTZ reduced comms revenue guidance by $400M. Carriers deferring wireless work ahead of new spectrum equipment next year. Wireline faces project roll-offs and permitting delays. KeyBanc sees wireline back to growth in early 2027; wireless takes longer — "customer-driven factors."
"KeyBanc views the communications delays as isolated from the rest of MasTec's business, which continues to show strong results."
KeyBanc cut its multiple to 16x 2027 earnings to reflect uncertain wireless recovery and E&C de-rating. Truist leans on the 0.48 PEG — cheap relative to growth.
Bull: Record $21.4B backlog (+30%), Superior Group adds data center/mission-critical exposure, pro forma leverage at 2.2x heading under 2x by year-end, EBITDA $384M (+40%, margins +100bps). Comms weakness looks isolated. At $258 you're paying sub-28x a raised FY26 guide with record backlog — the risk mostly priced.
Bear: Comms is a core segment, not a rounding error. The 16x 2027 multiple assumes recovery actually shows up — if wireless slips again on spectrum timing, the whole thesis pushes out a year. KeyBanc explicitly flagged 2027 recovery uncertainty. You get paid to wait, but "wait" carries an opportunity cost.
$21.4B BACKLOG (+30% YoY) — and management expects it HIGHER by year-end. They booked the demand. The only open question is conversion timing.
PWR just put up the kind of quarter that makes a 40x forward multiple feel less insane — REVENUE $9.56B (+11% vs consensus), ADJ EPS $4.24 (+29% vs consensus), BACKLOG $53.4B (+49% YoY). Stock's up 58% YTD and the cap just crossed $100B. But the Street can't agree on the value, and that spread IS the signal: TRUIST GOES TO $976 BUY while the pack lands $741-$785. That's a 25% gap between "this compounds" and "this is priced."
The beat was everything, not one metric. Management raised FY26 adjusted EPS to $16.45-$16.95 — +55% YoY at the midpoint — and added $600M to EBITDA guidance taking it to $4.09-$4.21B. A dozen analysts revised estimates upward post-print.
The engine is electric infrastructure. ELECTRIC REVENUE +44% WITH 33% ORGANIC, MARGINS +140BPS TO 11.5%. Management now sees Electric Grid & Gas Utility growing 20%-25% this year (from 10%-20%) and Technology & Load Centers at 220%-240% (from 100%-120%). That's the AI datacenter load wave showing up in the P&L, not just the slide deck.
Four acquisitions closed in the quarter add $1.2-$1.4B revenue and $120-$140M EBITDA. But the sharpest framing of the guide raise comes from Mizuho:
"Four acquisitions account for approximately 29% of the $4.55 billion midpoint revenue-guidance increase, with the remaining 71% reflecting second-quarter outperformance and improved existing-business visibility."
71% ORGANIC. That's the bull case in a single number.
Truist stands alone at $976 Buy. TD Cowen at $785 Buy, Bernstein $748 Market Perform, Mizuho $741 Neutral. The cluster roughly maps to 10-18% upside from here; Truist implies 46%. That's an unusual amount of disagreement after a beat this clean. The models agree on FY26 — they diverge on the terminal multiple, i.e., how much of the AI grid buildout PWR actually converts into sustained economics.
The 71/29 organic-vs-M&A split matters. The guide raise isn't an acquisition math trick; it's the underlying franchise getting more visible. Truist and TD Cowen both lean on the same point — broad-based growth across utility, generation, technology, and infrastructure, not one lucky datacenter contract carrying the quarter.
PWR has graduated from value name to momentum compounder. I don't fade a print this strong, but I also don't chase a 40x stock into a green open. Own it if you already do; buy weakness on the next AI capex scare. The tiebreaker between $741 and $976 is the next big grid/datacenter award print — or one slip in backlog conversion. Until then, the bias is with the tape, but the entry matters more than the direction.
Cantor's PT bump to $250 is a footnote — the stock trades at $283.54, 12% ABOVE their new number. Neutral stays Neutral. The real story here is the chasm between the bulls and bears into the AUG 6 PRINT.
Last quarter: 3% revenue beat and the stock STILL sold off. That tells you everything about positioning. High expectations, restructuring/layoffs, growth deceleration, and DBNRR sliding sequentially. Stock sits NEAR ITS 52-WEEK HIGH ($293.80) with a +41.5% YTD return. Expectations are maxed.
The analyst split is unusually wide:
"Cantor Fitzgerald expects the narrative heading into the second quarter of 2026 to focus on four key areas: gross margin trajectory, pace of growth deceleration, dollar-based net revenue retention stabilization, and restructuring execution and agentic AI."
That's the whole ballgame. NRR stabilization is the tell — if DBNRR stops sliding, the bears lose their best argument. If it keeps falling, the multiple compresses fast.
Options market pricing a significant post-earnings move. Eight announcements back, NET exceeded expectations twice — that's a low bar for a stock at $283 with a $140 Sell PT on the street. The r/r into this print is ugly for longs: limited multiple expansion left at highs, but real downside if the decel narrative gets any fuel. Note the restructuring — layoffs into growth decel is usually the tell that management sees the demand picture softening.
Bernstein keeps Outperform, $534 PT. Evercore steps up to Outperform, PT to $502 from $453. Both read the same tape: Q2 was a clean beat, EPS growth bottomed in 1H, and the data center power story gets better from here.
Q2 PRINT: EPS $3.18 BEAT BY 3%, SALES $8.53B BEAT BY 5%, SEGMENT PROFIT $1.97B BEAT BY 7%. Guide goes up — FY26 EPS to $13.50 (+2%), organic growth +200bps, margin guidance unchanged. STOCK AT $431, right under the $436.74 high, UP 31% YTD. Not cheap at 43x, but the market's paying for an inflection that's still ahead.
This is an 800VDC story. Eaton's got the grid-to-chip stack — solid-state transformers, DC breaker tech, power electronics, cold plates, CDUs — and the Resilient/Boyd deals filled the last gaps. As data center power shifts from AC to DC, the whole menu sits in one ticker.
"The first and second quarters of 2026 marked the bottom of year-over-year earnings per share growth, with expected margin expansion by the fourth quarter of 2026."
That's the rate-of-change tell. If the YoY compression is truly behind us, H2 prints get cleaner sequentially — and this tape pays up for durability. Multiple's the risk. But growth at 43x beats value traps at 12x right now.
Stifel keeps the $800 PT and Buy into Wednesday's print. Stock sits at $535.20 after a 177% year — call it ~50% implied upside if they deliver.
The thesis is simple: hyperscalers are spending. Alphabet and Amazon boosted CY2026 capex guidance by 8.1% and 10.0% respectively, and Stifel reads that straight through to SiTime's data center revenue — now 45-50% OF SALES.
"All four major hyperscalers reported demand exceeding available capacity."
That's the whole ballgame. When demand exceeds capacity at the four largest AI buyers, the timing content provider wins (mEMS is the differentiator, but the market cares about sockets, not specs).
Stifel models June quarter at $145M/$1.92 and September at $162.4M/$2.09 — expects a beat and raise on both. The analog upswing (TI, NXP, STM all confirming broadening recovery) is a modest tailwind — auto/industrial/aero-defense is just 18.7% of revenue. This is a data center story.
Last quarter: EPS $1.44 vs $1.17 est, revenue $113.57M, beat by ~10%. The Renesas timing business acquisition adds strategic ballast but won't move the tape Thursday.
Risk: a 177% run prices in a lot. A guide that merely meets — not beats — could ding the stock. But with capacity-constrained hyperscalers and a beat-and-raise setup, near-term r/r still skews positive.
Cantor's the only voice on FIVN this morning and it's a multiple-expansion call, not a fundamentals call. PT to $32 from $24 — that's 1.78x EV/CY27 sales vs 1.35x prior — and they did it DESPITE mixed Q2 checks. Stock sits at $28.84, $0.02 off the 52-week high, after a 65% six-month rip. Cantor sees ~11% left.
The broader tape supports the re-rate. Backlog conversion faster than expected (Mizuho), operating leverage inflecting early (Rosenblatt), fresh exec bench (new CEO/CTO/CSO), and S&P SmallCap 600 inclusion bringing passive flow. The multiple math isn't crazy either: 1.5x one-year avg NTM revenue, 4.4x three-year avg — even at 1.78x forward, you're still below the historical norm.
The bear read: a 65%-in-six-months stock getting valuation-driven PT bumps while checks are MIXED is the definition of late-cycle momentum. Not sure we can read too much into a $4 PT hike on multiple expansion — but at 1.78x CY27 sales, you're paying for the turn to be real. If backlog conversion stumbles, the air pocket is fast.
Mizuho is buying the dip into the Aug 11 FQ4 print. Reiterates Outperform, $1,100 PT vs $779.95 close — stock still 28% off the $1,085.68 high despite a 4x run since November (SOX +71% over the same span). The call rests on InP supply chain strength: AXTI, Landmark, and SEI all guiding strong, with September quarter revenue expectations now +35% QoQ. Mizuho sees EML InP lasers, NPO ramps, and CW/SiPho leadership as the bottleneck owners, plus OCS ramping with Google, Microsoft, and Amazon — call it a $90B+ TAM.
"Would be buyers into earnings with strong second half 2026 momentum expected."
(Nasdaq-100 inclusion effective May 18 adds passive flow support. Rosenblatt still sees supply-demand gap through 2030. Down 27% from peak vs SOX -5% — some derisking already happened, but the valuation debate is far from settled.)
Wedbush lights the match — Outperform initiation, $20 PT, MORE THAN 100% UPSIDE from the $9.83 print. First published research on the name from this firm, but consensus already sits Strong Buy with PTs clustered $19-22 (Canaccord at $22). The setup: $569M cash, ZERO debt, a $100M CHIPS R&D LOI from Commerce, and a neutral-atom quantum roadmap quietly building credibility.
The PT math is honest work — ~$2.50/share net cash plus ~$17.50/share from discounted future cash flows. They ran a 20.5% WACC. That's a fat discount rate, which tells you they're underwriting real execution risk, not just narrative.
"Wedbush's price target comprises approximately $2.50 of net cash per share and roughly $17.50 per share from the company's discounted future cash flows."
The bear case is just as obvious: Q1 rev $9.5M (+14% YoY) against a $33.6M operating loss. Stock comp and going-public costs inflate that, but this is still a pre-profit, milestone-driven story. The CHIPS $100M isn't wired — it's contingent on hitting development milestones. Watch CEO Kinsella's House testimony on the Quantum-Enhanced Critical Minerals Mapping Act. Policy is the catalyst path here, and the calendar is full.
Wedbush swings for the fences with an Outperform and $40 PT on initiation — roughly 2.7x the $14.95 close. The bull case is not about qubit count. It's about fidelity at scale, and that's the right frame for 2026.
"Fidelity rather than qubit count represents the 2026 milestone for Rigetti."
Cepheus-1-108Q is the proof point — twelve 9-qubit chiplets, the largest modular system on the market, GA'd across Rigetti's own cloud, Braket, Azure Quantum, and qBraid. Management is targeting ~99.5% median two-qubit gate fidelity by year-end, and prototypes are already printing 99.9% at 28ns gate speeds. That rate of change is what re-rates this name, not the revenue base.
Wedbush models Q4 2026 revenue at $14.8M — NEARLY HALF THE FULL-YEAR $30.5M ESTIMATE. Q1 grew 199% YoY off a tiny base, so the math is lumpy but heading the right way. The customer list is broadening too: Novera system sales, Moody's, Standard Chartered, the UK NQCC deployment, and the July 27 TangleLab award pairing Novera with HPE infrastructure at Pittsburgh Supercomputing Center under a $5M NSF grant.
Balance sheet is not the constraint. $568M net cash post-Q1, plus a $100M Commerce LOI (CHIPS Act money, government gets an equity stake). FCF burn improving to -$59M in 2026 from -$77M, even as opex jumps to ~$116M from $87M. They're spending to stay ahead of the fidelity curve.
The rest of the Street is constructive but lower: Benchmark Buy $25, Cantor Overweight $30, Craig-Hallum Buy $30 (adiabatic gate approach potentially becoming standard later this year). Wedbush's $40 is the outlier — a bet that fidelity milestones drive multiple expansion, not just revenue growth. If 99.5% median fidelity prints by Q4, $40 starts looking conservative.
Cantor lifts DT to $47 from $37 — but at $45.09 that's a shrug, not a shout. NEUTRAL. Thesis: hybrid-cloud modernization and renewal tailwinds carry into FY27 (ends March), and Logs consumption is growing robustly. The catch: ARR reacceleration timing is less certain because AI-native workloads are tracking slower than the narrative needs.
"The timing and magnitude of annual recurring revenue reacceleration remain less certain given relatively slower traction within AI-native workloads."
That's the bear line in a bull story. Bulls (DA Davidson at $60, TD Cowen at $50 — both Buy) see the reacceleration coming and think full-year guidance reads conservative. Cantor wants to see the print before paying up. At ~4% upside to the new PT, the r/r isn't screaming.
Starboard engagement just put two directors on the board (George Riedel, Dan Streetman). Analyst day could land Nov/Dec 2026. FedRAMP High authorization chase opens federal doors. Discount valuation + activist pressure + event calendar = the H2 setup is real. But the swing factor is the ARR print, and the comp is brutal: BTIG just lifted Datadog to $289 on AI-driven observability spend. DT's AI-native traction gap vs. DDOG's AI pull — that's the whole ballgame.
Beat, raise, 10% EPS growth — and the stock still fell 6%. Bernstein says that's the entry. Firm bumps PT to $564 from $559, keeps Outperform. (Modest $5 move; the message beats the number.)
Bears threw two punches after Q2: YoY margin contraction and doubts on the 8-12% EPS growth algorithm. Bernstein parries both. The margin drag splits into four buckets — hardgoods, helium, price-cost, Lincare — and the first three are temporary noise. Lincare is stickier, but that's a strategic home care bet, not a broken core gases franchise.
"The firm characterized most of the margin headwinds as temporary or strategic long-term decisions."
Adjusted EPS $3.91 vs $3.88 est. Revenue $8.07B vs $7.75B est — a real top-line beat, record quarterly sales. At 30.9x P/E with InvestingPro flagging slightly rich valuation, this isn't cheap. Guidance implies only modest near-term improvement, so no instant re-rate. But a 6% drawdown on quarterly noise in a compounder? That's the r/r.
Freedom Capital starts it with a Buy and $140 PT — 18% off the tape at $119.05. Mizuho's already at $180. Call that the range of conviction.
The thesis is clean: AI/datacenter demand, RECORD WFE SPENDING, and the biggest fab buildout in history pull Entegris along for the ride. They're mid-execution on a $1B+ global footprint expansion — their largest ever — with a new management team steering. Top priority: ramp qualifications, production, and shipments at that multi-year buildout while repairing the balance sheet. Current ratio sits at 3.21, so liquidity isn't the issue; leverage is.
"Entegris enters its next growth phase with its portfolio of leading-edge solutions intact and expanding end markets."
Mizuho's $180 bump (from $175) after its U.S. and Japan semi teams raised WFE forecasts for 2026-27 is the corroborating signal — WFE is the demand proxy that matters here. Leadership shuffle in Materials Solutions (Woodland retiring June 1, Blachier stepping in) fits the overhauled-management narrative. The $0.10 quarterly dividend is token, but a confident token.
Watch the $140 ceiling break. If WFE estimates keep climbing, that PT cluster migrates higher.
Cantor's the boldest call on the tape this morning: PT TO $327 FROM $226 — a 45% raise straight into the Aug-6 print. Stock's at $272.92, basically hugging the 52-week high ($278.76) after a 124% SIX-MONTH MELT-UP. This isn't contrarian; it's validation of a name that's already re-rated hard.
The bull case: AI-native observability traction, at-or-above-plan checks, accelerating AI workload production at key customers, Bits AI adoption gaining. Cantor sees another beat-and-raise, and the setup supports it — the 2026 guidance framework leaves H2 looking conservative. 80% GROSS MARGINS + 30% REVENUE GROWTH gives you the headroom to believe the story.
"At-or-above-plan checks and accelerating AI workload production at key customers."
That's the crux — the spend is real, not pipeline theater.
Everyone else is in the same zip code: BofA $305, MS $300, Citi $300, Benchmark $330 (Street high). Tight $300-330 band. Consensus is crowded, and the options market's implying a ~13% MOVE at the print. The bogey isn't whether DDOG beats — consensus says it does. The bogey is whether the beat's big enough to make the multiple work from $273.
Verdict: Tuesday's print is a formality. The options market prices a 7.8% move, but the headline quarter is locked in-line. The September guide, gross margin, and Helios timing decide the next leg.
Benchmark holds Buy, $685 PT, with Q2 estimates glued to consensus — $11.28B rev / $1.63 EPS vs $11.31B / $1.62 Street. No edge in that spread. Stock sits at $484.74, UP 177% IN A YEAR. This is a story stock now — the multiple only works if the AI compute narrative keeps compounding.
Benchmark's right: the call hinges on forward signals, not the print. Helios rack and EPYC Venice in full production — real, not slideware. The Core Scientific 2.5GW deal gives hard numbers to the accelerator demand story. Bulls stretch the TAM canvas (Stifel's $1.4T accelerator TAM by 2030, William Blair's $2T compute TAM), but everyone pulls the same rope directionally.
"With total-company expectations closely grouped, the earnings call should be judged primarily on the September guidance, gross margin and Helios timing."
Net: owning AMD into the print doesn't cost anyone their job. Guide down on any of those three and the 177% unwind gets ugly fast.
Wedbush finally picks up coverage with an OUTPERFORM and a $75 PT — that's ~2x from here ($36.44). The target comes from a 10-year DCF with a 22% WACC (they're underwriting real risk, not hockey-stick fantasy) and a 5% terminal growth rate. The bull case is straightforward: 335% revenue growth LTM, Q1 2026 print of $64.7M crushed estimates, guidance raised, and now the SkyWater consolidation adds a vertical integration angle to the narrative.
The valuation debate is really a bet on when quantum becomes a real P&L driver, not a lab experiment. Wedbush's $75 sits above Benchmark's recent $60 initiation — both want exposure to the sector leader in trapped-ion tech, but the wide PT spread tells you nobody has conviction on the shape of the curve yet.
"The consolidation of SkyWater from July 31 represents the most likely source of change to both its estimates and analytical framework following the company's earnings call."
That's the line to watch. Post-SkyWater, the model shifts from pure-play cloud access to owning more of the stack — better margin potential, more execution risk, and a very different capital allocation story. $13.6B market cap with more cash than debt gives them runway, but at this price you're paying for 2028+ to be real. PMs with tech sleeves should let this one run on the first pullback toward $32-33 rather than chase the initiation pop.
UBS just made this a 2027 story. PT to $225 from $200 with 2027 sales/EPS forecasts 17-19% ABOVE consensus — that's not a cosmetic bump, that's a positioning statement.
The thesis: data center-led infrastructure growth carries this momentum into next year. UBS sees 25% organic growth in 2027 vs street at 16%, EPS $6.91 vs $5.82 (30% earnings growth on top of the 55% expected this year). Q2 gives them cover: EPS $1.45 vs $1.16 est, organic +47%, EBITDA 23% above consensus — with a $2.5B backlog smoothing execution risk. Pricing and productivity offset $50M+ in tariff/inflation costs, which tells you the pricing power is real.
"Another blockbuster quarter" — UBS, on the Q2 print.
Bull case writes itself: growth accelerating, backlog visibility, data center budgets still expanding. Bear case: 43x P/E, InvestingPro flags overvalued, stock's up 72% in a year. You're paying for the 2027 acceleration, not the 2026 beat.
Evercore adds $210 PT (Outperform) — their number that matters: organic sales came in 22 points ahead of consensus. Beats of that magnitude are rare. Watch for the tape to start pricing 2027 as the base case, not the bull case.
Cantor's the one analyst actually stepping up into Thursday's print — PT to $126 from $107, Overweight, and it's a conviction call built on seat expansion, not multiple hope. The tape agrees: TEAM caught a bid while the rest of tech sold off.
The bull case: Cloud migrations + Jira Service Management + Teamwork Collection = durable enterprise seat growth into FY27. Stock at LESS THAN 11x CY27 FCF with 85% gross margins. AI monetization is the free option (Rovo early, but 65% AI usage uptake by engineers says the hooks are in).
The bear case is data center decay and conservative Cloud growth — not a quality debate. BofA cut to $105 on FY27-28 revenue assumptions. Raymond James trimmed estimates on DC declines. Even the bulls concede Data Center keeps bleeding; they just argue it's priced.
"The firm said the stock trades at less than 11 times calendar 2027 free cash flow."
Earnings Thursday AMC. Macquarie's street-high at $130, BofA's at $105 — that $25 spread is the Cloud growth debate in dollar terms. Low bar on Data Center, high bar on Cloud ARR. If seats are still expanding and JSM momentum holds, Cantor's $126 looks conservative by fall.